Researchers warn that men who regularly avoid prostate cancer screening appointments are 45% more likely to die from the disease.
Prostate cancer According to the University of California, San Francisco, it is the most common cancer among men and the second leading cause of cancer death.
But if the screening program is introduced at a national scale, especially those that measure prostate-specific antigen (PSA) levels in the blood – they can get men to receive treatment earlier.
So, according to news agency SWNS and others, they will have a better chance of being cured.
Filtering can also prevent Expensive treatments Related to advanced prostate cancer.
A new study examines the link between the persistent decline in male screening and the risk of dying from prostate cancer. It reveals a “sharp contrast” that emphasizes the potential consequences of avoiding screening. (iStock)
This is based on data from a randomized study of European Prostate Cancer Screening (ERSPC).
The study collected information from seven European countries – Finland, the Netherlands, Italy, Sweden, Switzerland, Belgium and Spain. SWNS said it is said to be the largest prostate cancer screening study in the world.
Common cancer types can be detected with new blood tests
The long-term data from this entity always suggests that PSA screening programs can lead to a 20% reduction in the risk of dying from prostate cancer.
“Sharp contrast”
Now, an analysis of 20-year follow-up data from ERSPC is the first to view the link between consistent declines Filter invitations Men are at risk of dying from this cancer.
It reveals a “sharp contrast” that emphasizes the potential consequences of avoiding screening.
Of the 72,460 men invited to the screening, about one in six were non-participants and skipped all dates.
SWNS said researchers from the Eras McC Cancer Institute at the University Medical Center, Dutch, chaired the analysis.
Of the 72,460 men invited to the screening, about one in six were non-participants and skipped every date.
The group has a 45% higher risk of death Prostate cancer According to the survey results, compared to those who attended the screening date.
One expert said choosing not to participate in screening is an option that may be driven by complex factors. (iStock)
SWN reported that when compared with the results from the control group (men who were never invited to do screening), people who participated in screening dates had a 23% lower risk of dying from prostate cancer, while those who did not faced by participants had a 39% lower risk.
Principal study author Renée Leeenen, MD, Ph.D. The choice to not participate in the screening may be driven by complex factors, said.
Click here to sign up for our health newsletter
Leenen at the Erasmus CM Cancer Institute in the Netherlands Healthy behavior Preventive care overall. ”
Experts “need to better understand who these people are, why they choose not to date and how to motivate them.”
She added: “This is the opposite behavior of those who may be healthier conscious and more likely to attend screening appointments… Our study shows that men who were invited to do screening but did not participate in screening are significantly higher at risk of dying from prostate cancer than men who did not provide screening or were screened.”
The long-term data from this entity always suggests that PSA screening programs can lead to a 20% reduction in the risk of dying from prostate cancer. (iStock)
Dr. Leon said experts “need to better understand who these people are, why they chose not to date and how to motivate them.”
She added: “doing this, “will help us design population-based prostate cancer screening programs that encourage higher informed participation rates… Addressing attendance in this way may be an important factor in the long-term success of the national prostate screening program,” SWNS reported.
For more health articles, please visit www.foxnews.com/health
“We need to better understand why these people may actively choose not to participate in screening despite being invited to attend, and how they link to poor phase-outs when diagnosed,” said Tobias Nordström, MD, urologist at the Karolinska Institute in Sweden.
SWNS said the results of the study are scheduled to be presented at the European Association of Urology (EAU) conference in Madrid, Spain this weekend.
Click here to get the Fox News app
Senior Medical Analyst at Fox News Dr. Mark SiegelHe was not involved in new research on prostate cancer risks and had previously called for the need for regular medical screening.
Siegel stressed the need for “diagnosis as early as possible to obtain better results”.
Fox News’ Angelica Stabile contributed the report.
